Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223594 · ClinicalTrials.gov registry record
Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 500
- Enrollment target
NCT06223594 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 500 participants.
The verdict
NCT06223594 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Acute pancreatitis (AP) is a common disease of the gastrointestinal tract that can result in emotional, physical, and financial burdens on the patient.
Interventions
- OTHER Intravenous Fluid Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2025-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223594
The ClinicalTrials.gov registry entry for NCT06223594 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous Fluid Therapy is the first listed.
NCT06223594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06223594 about?
NCT06223594 is a clinical study titled "Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol". Acute pancreatitis (AP) is a common disease of the gastrointestinal tract that can result in emotional, physical, and financial burdens on the patient.
What is the current status of trial NCT06223594?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2023-07-17. Estimated completion is 2025-07-22.
What interventions are being tested in trial NCT06223594?
The interventions under investigation include: Intravenous Fluid Therapy (OTHER).
Who is sponsoring clinical trial NCT06223594?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.